Persistent chorea in DYT6, due to anticholinergic therapy.
Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy; Sobell Department of Motor Neuroscience and Movement Disorders, University College London (UCL) Institute of Neurology, London, UK. Electronic address: elenaantelmi@gmail.com.
E
E
Antelmi
Sobell Department of Motor Neuroscience and Movement Disorders, University College London (UCL) Institute of Neurology, London, UK.
R
R
Erro
Department of Systems Medicine, University of Rome "Tor Vergata", Italy; Laboratory of Neurophysiology and Synaptic Plasticity, IRCCS Fondazione Santa Lucia, Rome, Italy.
A
A
Pisani
Sobell Department of Motor Neuroscience and Movement Disorders, University College London (UCL) Institute of Neurology, London, UK.
N
N
Mencacci
Sobell Department of Motor Neuroscience and Movement Disorders, University College London (UCL) Institute of Neurology, London, UK.
K P
KP
Bhatia
D000368:Aged; D051017:Apoptosis Regulatory Proteins / Q000235:genetics; D018680:Cholinergic Antagonists / Q000009:adverse effects*; D002819:Chorea / Q000139:chemically induced*; D004268:DNA-Binding Proteins / Q000235:genetics; D004421:Dystonia / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D008297:Male; D009154:Mutation; D009687:Nuclear Proteins / Q000235:genetics; D014282:Trihexyphenidyl / Q000009:adverse effects*
D051017:Apoptosis Regulatory Proteins; D018680:Cholinergic Antagonists; D004268:DNA-Binding Proteins; D009687:Nuclear Proteins; C474080:THAP1 protein, human; D014282:Trihexyphenidyl